Menu

Search

Stian Reimers

Stian Reimers

Dr Reimers studied natural sciences at Cambridge, where he also completed a PhD in experimental psychology. He holds other degrees from Imperial College London (MSc Science Communication) and Birkbeck (BA English Literature).

Prior to coming to City University London, he held postdoctoral positions at Warwick and UCL, most recently, a fellowship from the ESRC Centre for Economic Learning and Social Evolution.

Dr Reimers is interested in high-level cognition, in particular judgement and decision making. One particular interest is in the psychology of time - how humans and other animals represent and make decisions involving time, in particular how and why people's discounting of delayed rewards varies across individuals and contexts.

Research interests:
Other judgement and decision making interests include forecasting - how individuals and organisations can improve the predictions they make about future trends - and game theory - in particular, individual and contextual differences in strategies used for ultimatum, prisoner's dilemma and co-ordination games.

He also works on applying experimental psychology to policy issues, particularly the notion of what constitutes a 'fair' taxation structure. Further afield, Dr Reimers does work on executive control, cognitive ageing, sex differences and cerebral lateralisation.

He has wider interests in psychology, working regularly with the BBC and independent production companies on brain-science-related TV shows, and helping set up fun - yet valid - web-based psychology tests for the BBC website among other places. He also undertakes consultancy projects, examining consumer behaviour and the effects of interventions for major retailers and government departments.

Dr Reimers also has interests in using new technology in psychological research, extending from web-based research through running experiments on mobile phones, to work using Wii input devices - Balance Boards, accelerometers and the like - for recording behavioural data.

When it comes to tax, how do we decide what's fair?

Apr 08, 2016 16:38 pm UTC| Insights & Views Law

The tax dealings of a number of politicians have come under scrutiny this week, following news of their offshore holdings in the Panama Papers. The leaks have led to the resignation of the Icelandic prime minister and the...

1 

Economy

MOEX Russia Index Climbs as Oil, Gas, and Telecom Stocks Rally

Russian stocks closed higher on Saturday, driven by gains in the Oil Gas, Power, and Telecom sectors. The MOEX Russia Index rose 2.10% to end the session on a strong note. Top performers included NOVATEK PJSC (MCX:NVTK),...

Saudi Arabia Hits Record $137 Billion in Non-Oil Exports as Vision 2030 Gains Momentum

Saudi Arabias non-oil exports surged to an all-time high of 515 billion riyals ($137.29 billion) in 2024, according to the Saudi Press Agency (SPA). The 13% year-on-year increase highlights the kingdoms drive to diversify...

Pakistan Seeks 10 Billion Yuan Swap Boost, Eyes Panda Bond Launch in 2025

Pakistan has requested China to expand its currency swap line by 10 billion yuan ($1.4 billion), Finance Minister Muhammad Aurangzeb revealed during the IMF and World Bank Spring Meetings in Washington. The country already...

Wall Street Gains on Tech Rally Amid Hopes for U.S.-China Trade Easing

Wall Street closed higher on Friday, lifted by technology shares, as optimism over a potential easing of U.S.-China trade tensions buoyed markets. Alphabet (NASDAQ:GOOGL) surged 1.7% after surpassing earnings expectations...

Swiss National Bank Warns of Slower Growth Amid Rising Global Risks

Swiss National Bank (SNB) Chairman Martin Schlegel warned on Friday that rising global economic risks, fueled by U.S. tariffs and trade uncertainty, will likely slow Switzerlands economic growth. Speaking at the SNBs...

Politics

Trump Marks 100 Days with Policy Wins, Eyes Trade Deals and Peace Talks

U.S. President Donald Trump is celebrating his first 100 days in office by highlighting major policy shifts and setting ambitious goals for the next phase, White House officials said. Trump, who has moved quickly on...

Young Voters Rally Behind Pierre Poilievre Ahead of Tight Canadian Election

Conservative leader Pierre Poilievre is gaining strong support from young Canadians as he campaigns on the cost-of-living crisis ahead of Mondays election. At a rally north of Toronto, Poilievre called for change,...

Mahmoud Abbas Names Hussein al-Sheikh as Deputy, Signaling Future Palestinian Leadership Shift

Palestinian President Mahmoud Abbas has appointed Hussein al-Sheikh, a longtime confidant, as vice president of the Palestine Liberation Organisation (PLO), positioning him as a likely successor. The move, announced on...

U.S. Threatens Livestock Import Ban Over Mexico's Screwworm Control

The Trump administration warned Saturday it would restrict livestock imports from Mexico unless efforts against the New World screwworm pest are intensified. U.S. Agriculture Secretary Brooke Rollins sent a letter to her...

Trump and Zelenskiy Hold Historic Vatican Meeting Amid Ukraine Peace Push

U.S. President Donald Trump and Ukrainian President Volodymyr Zelenskiy met privately at the Vatican on Saturday during the funeral of Pope Francis, seeking to revive stalled peace talks with Russia. The 15-minute...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

Nintendo Unveils Switch 2 Amid Tariff Concerns and Soaring Demand

Nintendo offered fans an early hands-on experience with its new Switch 2 console at an event near Tokyo on Saturday, as concerns grow that tariffs could push prices higher. Since Mr. Trump became president, tariffs have...

Apple Plans to Shift All U.S. iPhone Production to India Amid China Trade Tensions

Apple Inc. (NASDAQ: AAPL) is reportedly planning to shift all iPhone assembly for the U.S. market to India as early as next year, in a strategic move to reduce reliance on China amid escalating U.S.-China trade tensions,...

Chinese AI Startup Behind Manus Raises $75M, Targets Global Expansion

Chinese AI startup Butterfly Effect, the creator of Manus AI, has raised $75 million in a funding round led by U.S.-based venture capital firm Benchmark, according to a Bloomberg report citing sources familiar with the...

Intel Sees Surge in Older Chip Demand Amid U.S.-China Trade War Fears

Intel (NASDAQ: INTC) is experiencing a rise in demand for its older-generation PC and server chips as the U.S.-China trade war intensifies, executives revealed after the companys latest earnings release. Economic...

Baidu Launches Advanced Ernie AI Models to Compete in China’s Growing AI Race

Baidu (NASDAQ:BIDU) has launched upgraded versions of its Ernie artificial intelligence models, intensifying its push in Chinas fast-evolving AI landscape. At a developer conference held in Wuhan, CEO Robin Li introduced...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.